Thermo Fisher Scientific Showcases Product Portfolio at Lab Trade Show
By LabMedica International staff writers Posted on 01 Aug 2018 |

Image: One model from the new series of TSG compact refrigerators (Photo courtesy of Thermo Fisher Scientific).
Thermo Fisher Scientific Inc. (Waltham, MA, USA) showcased innovations for research and clinical labs and also launched a new series of compact refrigerators at the 2018 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo held July 29 – August 2 in Chicago, USA.
At AACC 2018, Thermo Fisher displayed its range of LC-MS instruments, including the fully automated Cascadion SM Clinical Analyzer, Prelude LX-4 MD HPLC, and Endura MD Mass Spectrometer. Thermo Fisher’s lab solutions portfolio showcased at this year’s AACC included the recently CE-marked Phadia 200 instrument which requires less than six square feet of lab space and can run up to 700 different ImmunoCAP and EliA quantitative tests, including the recently cleared peanut allergen component ImmunoCAP Ara h6. Thermo Fisher also showcased its new B·R·A·H·M·S KRYPTOR GOLD immunoassay analyzer, which features increased capacity and has been developed for optimal automation, efficiency and precision.
Thermo Fisher showcased its Ion Torrent Oncomine solutions, including the Oncomine Dx Target Test, the first FDA-approved companion diagnostic for non-small cell lung cancer. The company also demonstrated its Ion GeneStudio S5 Prime system, as well as other oncology research assays designed for studies in blood-based cancers, liquid biopsy, childhood cancers and immuno-oncology. In addition, Thermo Fisher featured new compounds for antimicrobial susceptibility testing: delafloxacin and meropenem/vaborbactam. Also on display at the event were the recently announced Thermo Scientific B·R·A·H·M·S PCT direct point-of-care assay for procalcitonin (PCT) measurement in acute care settings and its novel range of ChromaCare flush solutions and ultrapure solvents for ultrahigh-performance LC-MS systems.
"Clinical customers and translational researchers demand analytical platforms that support higher throughput, accuracy and scalability," said Patrick Durbin, senior vice president and president of specialty diagnostics for Thermo Fisher Scientific. "The common goal is actionable data that's delivered with confidence, and we're highlighting our portfolio of leading products at AACC to support their needs, from research to the clinic."
At this year’s AACC, Thermo Fisher launched the new series of TSG compact refrigerators for clinical laboratories and patient care facilities requiring secure and energy-efficient storage of vaccines, medicines, lab kits and breast milk, all in a quiet unit with a small footprint. The new refrigerators have been designed to provide uninterrupted temperature stability and cleanroom-compatible readiness for reliable materials storage. They operate at a sound level of less than 35 dbA and have ENERGY STAR-rated performance, consuming significantly less energy than similar models to meet increasing demands for sustainability and reduced operating costs.
"Maintaining optimal cold storage conditions is of utmost importance in clinical settings to preserve the viability of stored materials, as is the need to maximize efficiencies by locating vaccines, medicines and lab kits close to their point of use," said Alex Esmon, senior product manager, cold storage, laboratory equipment, Thermo Fisher Scientific. "With this in mind, we have introduced the new series of high-performing refrigerators to offer our clinical customers confidence that their valuable materials are fully protected at all times. The solid state technology used in the TSG Series allows for minimal impact on the clinical environment through reduced operational noise and heat output, while the systems' small size maximizes working space."
At AACC 2018, Thermo Fisher displayed its range of LC-MS instruments, including the fully automated Cascadion SM Clinical Analyzer, Prelude LX-4 MD HPLC, and Endura MD Mass Spectrometer. Thermo Fisher’s lab solutions portfolio showcased at this year’s AACC included the recently CE-marked Phadia 200 instrument which requires less than six square feet of lab space and can run up to 700 different ImmunoCAP and EliA quantitative tests, including the recently cleared peanut allergen component ImmunoCAP Ara h6. Thermo Fisher also showcased its new B·R·A·H·M·S KRYPTOR GOLD immunoassay analyzer, which features increased capacity and has been developed for optimal automation, efficiency and precision.
Thermo Fisher showcased its Ion Torrent Oncomine solutions, including the Oncomine Dx Target Test, the first FDA-approved companion diagnostic for non-small cell lung cancer. The company also demonstrated its Ion GeneStudio S5 Prime system, as well as other oncology research assays designed for studies in blood-based cancers, liquid biopsy, childhood cancers and immuno-oncology. In addition, Thermo Fisher featured new compounds for antimicrobial susceptibility testing: delafloxacin and meropenem/vaborbactam. Also on display at the event were the recently announced Thermo Scientific B·R·A·H·M·S PCT direct point-of-care assay for procalcitonin (PCT) measurement in acute care settings and its novel range of ChromaCare flush solutions and ultrapure solvents for ultrahigh-performance LC-MS systems.
"Clinical customers and translational researchers demand analytical platforms that support higher throughput, accuracy and scalability," said Patrick Durbin, senior vice president and president of specialty diagnostics for Thermo Fisher Scientific. "The common goal is actionable data that's delivered with confidence, and we're highlighting our portfolio of leading products at AACC to support their needs, from research to the clinic."
At this year’s AACC, Thermo Fisher launched the new series of TSG compact refrigerators for clinical laboratories and patient care facilities requiring secure and energy-efficient storage of vaccines, medicines, lab kits and breast milk, all in a quiet unit with a small footprint. The new refrigerators have been designed to provide uninterrupted temperature stability and cleanroom-compatible readiness for reliable materials storage. They operate at a sound level of less than 35 dbA and have ENERGY STAR-rated performance, consuming significantly less energy than similar models to meet increasing demands for sustainability and reduced operating costs.
"Maintaining optimal cold storage conditions is of utmost importance in clinical settings to preserve the viability of stored materials, as is the need to maximize efficiencies by locating vaccines, medicines and lab kits close to their point of use," said Alex Esmon, senior product manager, cold storage, laboratory equipment, Thermo Fisher Scientific. "With this in mind, we have introduced the new series of high-performing refrigerators to offer our clinical customers confidence that their valuable materials are fully protected at all times. The solid state technology used in the TSG Series allows for minimal impact on the clinical environment through reduced operational noise and heat output, while the systems' small size maximizes working space."
Latest AACC 2018 News
- Mesa Biotech Showcases PCR Testing Platform at Clinical Expo
- Mindray Medical Unveils Chemiluminescence Immunoassay System at AACC 2018
- Abbott Diagnostics Displays Alinity Family of Systems
- Roche Diagnostics Highlights Latest Clinical Lab Solutions at AACC
- Sysmex Highlights Innovations in Flow Cytometry, Urinalysis and Hematology
- Ortho Clinical Diagnostics Unveils Next-Gen Analyzer at Lab Show
- Snibe Diagnostic Presents Immunoassay Systems and Biochemistry Analyzers
- EKF Diagnostics Highlights Assay Kit and POC Analyzer at AACC 2018
- Randox Laboratories Showcases Advances in Biotechnology at Clinical Lab Expo
- Beckman Coulter Life Sciences Highlights Clinical Flow Cytometry Portfolio
- Beckman Coulter Features New Hematology Analyzers and Lab Automation
- Carolina Liquid Chemistries Promotes Family of Clinical Chemistry Analyzers
- Orion Diagnostica Showcases Rapid Test and Molecular Platform at Lab Show
- Saladax Biomedical Launches Game-Changing Assays at AACC 2018
- SeraCare Life Sciences Promotes New AccuSpan Panel at Lab Expo
- Sekisui Diagnostics Showcases Clinical Chemistry and Immunoassay Analyzers
Channels
Clinical Chemistry
view channel
AI-Powered Blood Test Accurately Detects Ovarian Cancer
Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more
Automated Decentralized cfDNA NGS Assay Identifies Alterations in Advanced Solid Tumors
Current circulating cell-free DNA (cfDNA) assays are typically centralized, requiring specialized handling and transportation of samples. Introducing a flexible, decentralized sequencing system at the... Read moreMass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication
Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more
First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read moreMolecular Diagnostics
view channel
First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis
Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more
New Molecular Label to Help Develop Simpler and Faster Tuberculosis Tests
Tuberculosis (TB), the deadliest infectious disease globally, is responsible for infecting an estimated 10 million people each year and causing over 1 million deaths annually. While chest X-rays and molecular... Read more
Biomarker Discovery Paves Way for Blood Tests to Detect and Treat Osteoarthritis
The number of individuals affected by osteoarthritis is projected to exceed 1 billion by 2050. The primary risk factor for this common, often painful chronic joint condition is aging, and, like aging itself,... Read moreHematology
view channel
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1.25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for... Read more
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read morePathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read moreTechnology
view channel
Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more